MedPath

A 24-month Outcomes of Single- Vs Multiple-visit Revascularization

Not Applicable
Recruiting
Conditions
Necrotic Immature Permanent Incisors
Registration Number
NCT06762821
Lead Sponsor
Minia University
Brief Summary

The current randomized clinical trial will be conducted to evaluate the 24-month clinical and radiographic outcomes after revascularization of asymptomatic necrotic immature permanent maxillary incisors using single- or multiple-visit protocol.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Compliant healthy patients who had at least one immature maxillary permanent incisor requiring nonsurgical root canal treatment.
  • Patients presenting with a diagnosis of pulp necrosis with chronic apical periodontitis confirmed by history, clinical, radiographic and operative examination.
  • Patient without previous endodontic treatment in affected tooth.
Exclusion Criteria
  • Patients with systemic conditions (medical, developmental or behavioral) that make routine dental treatment difficult.
  • Patients taking medications that can interfere with healing or hemostasis.
  • Patients with allergy to local anesthetics
  • Children who will not comply to recall program.
  • Teeth with extensive loss of coronal tissue that require restoration with a post
  • Teeth with internal or external root resorption

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Participants experiencing Pain after treatmentFrom enrollment to the end of treatment at 24 months

Zero is equivalent to no pain and 1 indicates presence of pain that necessitate taking pain killer

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Minia University Dental Hospita

🇪🇬

Minya, Egypt

Minia University Dental Hospita
🇪🇬Minya, Egypt
Faculty of Dentistry, Minia University
Contact
0020159939498

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.